Author

Pauline Wils 1

1 CHRU Lille, Lille Cedex, France

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

Pauline Riviere, Joel Pekow, Nassim Hammoudi, Pauline Wils, Peter De Cruz, Chritina Pu Wang, Miriam Mañosa Ciria, Jacob E. Ollech, Matthieu Allez, Maria Nachury, Michael A. Kamm, Mayo Ahanori, Marc Ferrante, Anthony Buisson, Siddarth Singh, David Laharie, Momar Diouf, Mathurin Fumery

CORRELATION BETWEEN THE LÉMANN INDEX AND THE INFLAMMATORY BOWEL DISEASE- DISABILITY INDEX IN CROHN’S DISEASE

Clémentine Farré, Mustapha Azahaf, Maria Nachury, Romain Gerard, Julien Branche, Pauline Wils, Pierre Desreumaux, Olivier ERNST, Benjamin Pariente

CROHN?S DISEASE (CD) PATIENTS WITH HIGH BODY MASS INDEX PRESENT MORE FREQUENT AND RAPID LOSS OF RESPONSE TO INFLIXIMAB.

loic guerbau, Romain Gerard, Nicolas Duveau, Pierre Desreumaux, Medina Boualit, Julien Branche, Vincent Maunoury, Louise Libier, Stephane Cattan, Corinne Gower Rousseau, Angelique Cotteau-leroy, Maria Nachury, Benjamin Pariente, Pauline Wils

EFFICACY AND SAFETY OF GOLIMUMAB IN CROHN’S DISEASE : A FRENCH NATIONAL RETROSPECTIVE STUDY

Chloé Martineau, Bernard Flourie, Pauline Wils, Thibaut Vaysse, Romain Altwegg, Anthony Buisson, Aurelien Amiot, Guillaume Pineton de Chambrun, Vered Abitbol, Mathurin Fumery, Xavier Hebuterne, Stéphanie Viennot, David Laharie, Laurent Beaugerie, Stéphane Nancey, Harry Sokol

LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB IN REFRACTORY CROHN’S DISEASE PATIENTS: A MULTICENTER RETROSPECTIVE EXPERIENCE

Pauline Wils, Yoram Bouhnik, Pierre Michetti, Bernard Flourie, Hédia Brixi, Anne Bourrier, Matthieu Allez, Bernard Duclos, Jean-Charles Grimaud, Anthony Buisson, Aurelien Amiot, Mathurin Fumery, Xavier Roblin, Laurent Peyrin-Biroulet, Jerome Filippi, Guillaume Bouguen, Vered Abitbol, Benoit Coffin, Marion Simon, David La

No Severe Neonatal And Maternal Complications in Female Patients With Inflammatory Bowel Diseases Treated With Ustekinumab or Vedolizumab During Pregnancy

Pauline Wils, Philippe Seksik, Carmen Stefanescu, Stéphane Nancey, Matthieu Allez, David Laharie, Guillaume Pineton de Chambrun, Romain Altwegg, Cyrielle Gilletta De Saint Joseph, Lucine Vuitton, Stéphanie Viennot, Mélanie Serrero, Mathurin Fumery, Guillaume Savoye, Michael Collins, Hédia Brixi, Guillaume Bouguen, Noémie T

Perianal lesions in Crohn's disease at diagnosis: Analysis of Epimad registry from 2007 to 2012 in a population based-study

Pauline Wils, Ariane Leroyer, Mathurin Fumery, Alonso Fernandez Nistal, Daniela Bojic, Rocco D'Ambrosio, Hélène Sarter, Guillaume Savoye, Corinne Gower-Rousseau, Benjamin Pariente

TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUMAB TREATMENT IN CROHN’S DISEASE PATIENTS

Claire Painchart, Séverine Brabant, Nicolas Duveau, Pauline Wils, Medina Boualit, Maria Nachury, Julien Branche, Romain Gerard, Pierre Desreumaux, Myriam Labalette, Benjamin Pariente

USTEKINUMAB EFFICACY AND SAFETY IN CROHN’S DISEASE PATIENTS REFRACTORY TO CONVENTIONAL AND ANTI-TNF THERAPY: A MULTICENTER RETROSPECTIVE EXPERIENCE

Pauline Wils, Yoram Bouhnik, Pierre Michetti, Bernard Flourie, Hedia Brixi- Benmansour, Jacques Cosnes, Matthieu Allez, Bernard Duclos, Jean-Charles Grimaud, Anthony Buisson, Aurelien Amiot, Mathurin Fumery, Xavier Roblin, Laurent Peyrin-Biroulet, Jerome Filippi, Guillaume Bouguen, Vered Abitbol, Benoit Coffin, Marion Sim

Item 1 - 9 / 9
1